Multiomic approach boosts disease prediction accuracy beyond traditional methods

Study highlights the significant enhancement in predicting common diseases like heart disease, diabetes, Alzheimer’s, and prostate cancer by integrating polygenic risk scores (PRSs) and gut microbiome scores with conventional risk factors, showcasing the potential of multiomic approaches in personalized medicine.

Bipartisan letter questions FDA’s ‘narrow’ interpretation for priority review vouchers

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 29, 2024

RSV Severity, Deaths on Par With Flu and COVID

In the years before the introduction of respiratory syncytial virus (RSV) vaccines, the virus was linked with substantial hospitalizations, intensive care unit (ICU) admissions, and

November 14, 2024

Beneficial Produce Scripts; Aortic Dissection Deaths Up; New Opioid & Cardiac Arrest

In people at risk for or having poor cardiometabolic health, produce prescriptions resulted in greater fruit and vegetable consumption and better glycated hemoglobin, blood pressure,

September 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.